OL
RMD icon

OneFund LLC’s ResMed RMD Stock Holding History

OneFund LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$89.4K Sell
401
-23
-5% -$5.73K 0.06% 277
2025
Q4 		$102K Buy
424
+27
+7% +$6.91K 0.06% 253
2025
Q3 		$109K Buy
397
+11
+3% +$3K 0.07% 235
2025
Q2 		$100K Buy
+386
New +$92.1K 0.07% 236

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OneFund LLC's RMD Position: Q1 2026 in Review

OneFund LLC reduced its ResMed (RMD) stake by 5.4% in Q1 2026, selling an estimated $5.73K and leaving 401 shares worth $89.4K. The position accounts for 0.06% of the portfolio, ranked #277.

OneFund LLC first reported a position in RMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $109K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • OneFund LLC held 401 shares of ResMed worth $89.4K as of Q1 2026.
  • OneFund LLC sold 23 ResMed shares in Q1 2026, an estimated $5.73K.
  • ResMed made up 0.06% of OneFund LLC's portfolio in Q1 2026, its #277 holding.
  • OneFund LLC first reported a position in ResMed in Q2 2025 and has held it in 4 quarters since.
  • OneFund LLC's ResMed position peaked at $109K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.